                               SEQUENCE LISTING

<110> MYTIDE THERAPEUTICS, INC.
 
<120> A MANUFACTURING PROCESS FOR PEPTIDE AND PROTEIN PRODUCTION

<130> 5679.1002-002 PCT

<140> PCT/US2020/037441
<141> 2020-06-12

<150> 63/009,563
<151> 2020-04-14

<150> 62/861,821
<151> 2019-06-14

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 13
<212> PRT
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: 
      acyl carrier protein (ACP (65-74) sequence"

<220>
<221> source
<223> /note="N-term amino"

<220>
<221> source
<223> /note="C-term carboxy"

<400> 1
Val Gln Ala Ala Ile Asp Tyr Ile Asn Gly His Ile Val 
1               5                   10              


<210> 2
<211> 22
<212> PRT
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: 
      Pexiganan sequence"

<220>
<221> source
<223> /note="N-term NH2"

<220>
<221> source
<223> /note="C-term amide"

<400> 2
Gly Ile Gly Lys Phe Leu Lys Lys Ala Lys Lys Phe Gly Lys Ala Phe 
1               5                   10                  15      


Val Lys Ile Leu Lys Lys 
            20          


<210> 3
<211> 42
<212> PRT
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: 
      Beta amyloid sequence"

<220>
<221> source
<223> /note="N-term amino"

<220>
<221> source
<223> /note="C-term carboxy"

<400> 3
Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys 
1               5                   10                  15      


Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile 
            20                  25                  30          


Gly Leu Met Val Gly Gly Val Val Ile Ala 
        35                  40          


<210> 4
<211> 102
<212> PRT
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: 
      102-mer sequence"

<220>
<221> source
<223> /note="N-term NH"

<220>
<221> source
<223> /note="C-term NH2"

<400> 4
Met Tyr Gly Lys Leu Asn Asp Leu Leu Glu Asp Leu Gln Glu Val Leu 
1               5                   10                  15      


Lys Asn Leu His Lys Asn Trp His Gly Gly Lys Asp Asn Leu His Asp 
            20                  25                  30          


Val Asp Asn His Leu Gln Asn Val Ile Glu Asp Ile His Asp Phe Met 
        35                  40                  45              


Gln Gly Gly Gly Ser Gly Gly Lys Leu Gln Glu Met Met Lys Glu Phe 
    50                  55                  60                  


Gln Gln Val Leu Asp Glu Leu Asn Asn His Leu Gln Gly Gly Lys His 
65                  70                  75                  80  


Thr Val His His Ile Glu Gln Asn Ile Lys Glu Ile Phe His His Leu 
                85                  90                  95      


Glu Glu Leu Val His Arg 
            100         


